<DOC>
	<DOCNO>NCT02176109</DOCNO>
	<brief_summary>In study , investigator study prognostic role oxidative stress metabolism iron Acute myeloid leukemia .</brief_summary>
	<brief_title>Metabolism Des LAM</brief_title>
	<detailed_description>Primary goal study Evaluate characteristic regulatory network iron redox balance leukemic cell , study correlation prognosis AML patient ( term response induction chemotherapy survival ) metabolism marker . Secondary one areto assess impact induction therapy marker oxidative stress correlate biological iron redox metabolism molecular status patient ( eg Flt3/IDH/CEBPA/NPM ... ) . Eligibility criteria patient diagnostic de novo acute myeloid leukemia ( promyelocytic exclude ) age 18 100 year .</detailed_description>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>de novo acute myeloid leukemic patient 18 year 99 year diagnosis age 18 year promelocytic leukemia secondary leukemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>